BioNeutra Global Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was CAD 3.81 million compared to CAD 5.84 million a year ago. Net loss was CAD 0.76227 million compared to CAD 0.065798 million a year ago. Basic loss per share from continuing operations was CAD 0.02. Diluted loss per share from continuing operations was CAD 0.02. For the nine months, sales was CAD 11.13 million compared to CAD 19.35 million a year ago. Net loss was CAD 2.18 million compared to CAD 1.02 million a year ago. Basic loss per share from continuing operations was CAD 0.05 compared to CAD 0.02 a year ago. Diluted loss per share from continuing operations was CAD 0.05 compared to CAD 0.02 a year ago.